Journal of Medicinal Chemistry · 2011 · 37 citations · 18 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsLigand BindingLigand-based DesignMacrocyclic Drug DesignPotency OptimizationStructure-activity Relationship AnalysisBenzyl Protecting GroupsSelectivitySpirocyclic ScaffoldsTreatment Of TrypanosomiasisTrypanocidal Therapy
We describe novel acetohydroxamic acid derivatives with potent activity against cultured bloodstream-form Trypanosoma brucei and selectivity indices of >1000. These analogues were derived from conformationally constrained, lipophilic, spiro carbocyclic 2,6-diketopiperazine (2,6-DKP) scaffolds by attaching acetohydroxamic acid moieties to the imidic nitrogen. Optimal activity was achieved by placing benzyl groups adjacent to the basic nitrogen of the 2,6-DKP core. S-Enantiomer 7d was the most active derivative against T. brucei (IC(50) = 6.8 nM) and T. cruzi (IC(50) = 0.21 μM).
18
Influenza virus M2 protein has ion channel activity
Lawrence H. Pinto, Leslie J. Holsinger, Robert A. Lamb · Cell · 1992 · 1.2K citations
The molecular basis of the specific anti‐influenza action of amantadine.
Alan Hay, Adrian J. Wolstenholme, J.J. Skehel et al. · The EMBO Journal · 1985 · 855 citations · Full text
Fabienne Dufernez, Cédric Yernaux, Delphine Gerbod et al. · Free Radical Biology and Medicine · 2005 · 98 citations
The rise and fall of sleeping sickness
Michael P. Barrett · The Lancet · 2006 · 89 citations